fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Alkem Laboratories Ltd

Alkem Laboratories Ltd

Updated on May 26, 2020

Stock/Share Code - ALKEM

Alkem Laboratories is a leading Indian Pharmaceutical company with Global operations, engaged in the development, Manufacture and sale of Pharmaceutical and Nutraceutical Products.(Source : 201903 Annual Report Page No: 04)

Below is the details of ALKEM Alkem Laboratories Ltd

Market Cap₹27,056 Cr.
Current Price ₹2,282.05 as on 1 Jun 20
52 Week High / Low Price₹2,882.1 / ₹1,660
Face Value₹2
Stock P/E22.85
Book Value₹501.34
Dividend Yield0.97 %
ROCE17.09 %
ROE15.48 %
Sales Growth (3yrs)13.47 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 21.98%
Cons: Tax rate seems low

Alkem Laboratories Ltd Price Chart

Alkem Laboratories Ltd Price Chart

Alkem Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹137.85 28.53 ₹113,788.46 Cr. 0.63 ₹399.84 Cr. -2.03 14.25 8184.94 11.19
2. Dr Reddy's Labs ₹3,953.55 33.39 ₹67,652.81 Cr. 0.49 ₹781.1 Cr. 71.52 10.41 4448.90 12.42
3. Cipla ₹642.5 33.79 ₹52,256.4 Cr. 0.46 ₹245.95 Cr. -33.02 -0.63 4376.19 10.94
4. Aurobindo Pharma ₹725.65 16.67 ₹43,690.51 Cr. 0.40 ₹705.45 Cr. -2.26 11.87 5895.00 18.45
5. Biocon ₹385.5 62.53 ₹42,564 Cr. 0.14 ₹123.4 Cr. -42.26 3.41 1581.00 13.39
6. Torrent Pharma. ₹23.95 39.00 ₹39,979.07 Cr. 0.72 ₹314 Cr. 121.13 4.85 1946.00 12.66
7. Cadila Health. ₹349.55 25.02 ₹35,278.17 Cr. 1.02 ₹373.9 Cr. -26.54 1.68 3638.10 15.35
8. Alkem Lab 22.85 ₹27,056.36 Cr. 0.97 ₹348.57 Cr. 44.50 3.94 1596.40 17.09

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Alkem Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019
Sales -1,0061,1441,5621,4231,1551,2701,4401,5361,4681,4991,8951,596
YOY Sales Growth %18.07%-2.59%17.67%22.59%14.86%10.96%-7.78%7.94%27.06%18.00%31.55%3.94%
Expenses -8969931,1261,1091,0801,0901,1371,2121,2301,2331,4101,233
Material Cost %38.14%43.83%37.50%35.77%41.47%38.94%38.47%40.20%41.28%38.13%39.22%34.68%
Employee Cost %15.81%17.19%14.22%15.69%19.01%19.12%15.86%15.89%16.69%18.92%14.54%17.67%
Operating Profit10915143631475180303324238265485364
OPM %11%13%28%22%7%14%21%21%16%18%26%23%
Other Income30242722251924519133127
Interest5811761097191010
Depreciation202326283032333541404043
Profit before tax11514442630164158285287215229465338
Tax %-7%22%22%29%6%18%16%16%11%8%7%-3%
Net Profit12311233121360129238241191211434349
EPS in Rs10.279.3827.6617.815.0210.8319.9320.1815.9617.6236.3029.15
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales -9741,1581,3441,6301,9242,2912,6603,0723,9114,5485,2815,7146,457
Sales Growth %9.05%18.97%16.03%21.30%18.04%19.07%16.11%15.49%27.29%16.30%16.11%8.20%
Expenses -8481,0131,1361,3191,5181,8622,2622,7273,1803,6684,3084,6675,106
Material Cost %49.40%49.22%44.88%43.70%40.24%39.39%43.02%45.53%39.56%39.47%39.30%39.76%
Manufacturing Cost %6.25%6.25%3.47%5.41%6.09%6.05%5.46%4.09%6.96%6.44%6.62%6.47%
Employee Cost %11.45%11.56%14.04%15.44%14.34%16.08%17.05%18.25%16.36%16.20%16.59%17.06%
Other Cost %19.99%20.40%22.11%16.39%18.23%19.76%19.49%20.89%18.43%18.55%19.06%18.38%
Operating Profit1261462083114064293983467318809731,0481,352
OPM %13%13%15%19%21%19%15%11%19%19%18%18%21%
Other Income4859781111351681651822401151016689
Interest15152037537984735924322831
Depreciation20212127283643607476108141164
Profit before tax1391692453574604824363958398949349441,246
Tax %-5%6%3%10%6%3%-1%7%17%1%23%15%
Net Profit1451582383224324674403687008837168001,184
EPS in Rs119.60130.13196.93266.69357.80387.04364.6730.0258.5773.8759.8866.9099.03
Dividend Payout %8%9%6%6%6%5%5%13%22%20%22%24%

Compounded Sales Growth

  • 10 Years:: 17.30%
  • 5 Years:: 16.52%
  • 3 Years:: 13.47%
  • TTM:: 19.56%

Compounded Profit Growth

  • 10 Years:: 18.69%
  • 5 Years:: 12.63%
  • 3 Years:: 4.15%
  • TTM:: 76.98%

Return on Equity

  • 3 Years:: 4.52%
  • 1 Year:: 26.11%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital -12121212121212242424242424
Equity Capital11.9611.9611.9611.9611.9611.9611.9623.9123.9123.9123.9123.91
Reserves8349731,1931,4481,8522,2912,7033,0773,5764,3694,8615,4415,970
Borrowings288403707288241,2299471,103380368548503821
Other Liabilities -1432072843834784795406578431,1371,3811,3241,372
Trade Payables79112174163259254276347466685819754629
Advance from Customers0005235816272528
Other liability items6495110215217222258303360426537542743
Total Liabilities1,2771,5951,5592,5713,1664,0114,2024,8614,8225,8986,8147,2928,187
Fixed Assets -3723903924846658329098708751,1261,4711,6061,652
Gross Block4344734984846658329091,1569451,2631,7141,973
Accumulated Depreciation6283106000028670137243367
CWIP1368000096147218299382413
Investments1932620533725799401,0711,1581,5181,5441,6961,736
Other Assets -7001,1731,1392,0332,1292,6002,3522,8242,6443,0373,5003,6094,386
Inventories2061961762283094535055485908591,024991968
Trade receivables981061171622522922903754806338759671,270
Cash Equivalents300728662980493965123633524199278398643
Loans n Advances951431971001522371871907681,0381,2731,341136
Other asset items00-125639236531,2481,07728130749-891,369
Total Assets1,2771,5951,5592,5713,1664,0114,2024,8614,8225,8986,8147,2928,187

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity -188245-8419815297264242630499318743
Profit from operations1331562423314164404053637748901,0121,074
Receivables-1-8-10-46-90-401-87-129-157-243-104
Inventory-291020-52-81-144-52-44-42-269-16533
Payables-1156639955981219265200-102
Loans Advances12-13-357-61-84-57-41-3600-3416
Interest paid-13-140000000000
Direct taxes-19-410-67-97-107-109-106-147-205-181-204
Other operating items117100-4283780071-45-273740
Cash from Investing Activity --11718542-723-279-349119-260311-362-273-311
Fixed assets purchased-73-31-28-117-244-203-97-133-171-460-499-355
Fixed assets sold000011333862
Investments purchased-339-1940-23-270-27000-4200
Investments sold273375200001010233091129
Investment income000000500000
Interest received2235509685159202931481077335
Dividends received000000101012
Invest in subsidiaries0000-39-530-238-59-215-125-174
Other investing items000-680188-226-5-8635623917950
Cash from Financing Activity --11-2-2462519274-39526-958-125-60-276
Proceeds from borrowings31514662944220201-696151880
Repayment of borrowings00000-17-279-46-26-300-32
Interest paid fin00-20-3700-84-73-53-24-32-28
Dividends paid-14-17-150-53-79-32-57-183-86-216-216
Other financing items00-30-21-52000000
Net Cash Flow60428-6699-10821-128-1713-15156

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %14%13%19%22%21%18%15%11%22%21%19%17%
Debtor Days373432364846404545516062
Inventory Turnover5.095.777.238.087.166.015.565.846.876.285.615.67

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Alkem Laboratories Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.